GW Biorepository Now a Core Facility

The George Washington University (GW) is pleased to announce that the GW Biorepository is now a core facility. Housed at the GW School of Medicine and Health Sciences, the GW Biorepository received designation as a shared resource available to all GW investigators and is accredited by the College of American Pathologists.

The GW Biorepository is a comprehensive, state-of-the-art resource for bio-specimen processing, storage, and disbursement designed to help today's leading investigators facilitate their research. In existence since 1994, the GW Biorepository is funded by the National Cancer Institute and includes 100,000 specimens from various NIH-funded cooperative projects, including the AIDS and Cancer Specimen Resource, the AIDS Malignancy Consortium, Women's Interagency HIV Study, and START Insight.

The facility's director, Sylvia Silver, DA, and associate director, Jeffrey Bethony, PhD, both professors of microbiology, immunology, and tropical medicine at the GW School of Medicine and Health Sciences, can be contacted for more information and costs at ssilver [at] gwu [dot] edu ( ssilver[at]gwu[dot]edu ) and jbethony [at] gwu [dot] edu (jbethony[at]gwu[dot]edu). The GW Biorepository is located in Ross Hall, rooms 118 and 119. It is electronically monitored to ensure proper environmental conditions for specimens.

Much of the infrastructure to support GW research is organized in scientific cores meant to facilitate discovery. These facilities offer a wide range of services, including cutting-edge technologies and high-end instrumentation coupled with technical support for research. In addition to the GW Biorepository, shared resources available to all GW investigators, often for a fee-for-service charge, include:

For more information on the GW Biorepository, visit smhs.gwu.edu/mitm-gwbiorepository/.

This announcement was provided by the GW School of Medicine and Health Sciences.

Latest News

Glioblastoma is the most aggressive primary brain cancer in adults. Even with treatment, just over 6 percent of patients survive five years or more. But there's good news: GW Cancer Center researchers are bringing hope for more precise, less invasive, and more effective treatments.
Sharad Goyal and Christina Puchalski were honored for their groundbreaking contributions to advancing cancer treatment and spiritual care in clinical medicine.
Sara Richman found her calling early, volunteering on a crisis hotline as a teen. Now an oncology social worker, she’s still driven by the same instinct: to connect, to listen, and to help. When she’s not supporting patients, you’ll probably find her at a concert. She’s been hooked on live music…